scispace - formally typeset
S

Serge Muyldermans

Researcher at Vrije Universiteit Brussel

Publications -  323
Citations -  30516

Serge Muyldermans is an academic researcher from Vrije Universiteit Brussel. The author has contributed to research in topics: Single-domain antibody & Antibody. The author has an hindex of 80, co-authored 305 publications receiving 26561 citations. Previous affiliations of Serge Muyldermans include Dalian University of Technology & Université libre de Bruxelles.

Papers
More filters
Journal ArticleDOI

Development of 177Lu-nanobodies for radioimmunotherapy of HER2-positive breast cancer: evaluation of different bifunctional chelators.

Matthias D'Huyvetter, +12 more
- 01 Mar 2012 - 
TL;DR: The in-house developed anti-HER2 nanobody 2Rs15dHIS can be successfully labeled with (177) Lu using different bifunctional chelators, and both macrocyclic and acyclic chelator show high stability in time.
Journal ArticleDOI

Development of vegfr2-specific nanobody pseudomonas exotoxin a conjugated to provide efficient inhibition of tumor cell growth

Mahdi Behdani, +11 more
- 25 Jan 2013 - 
TL;DR: It is demonstrated that this immunotoxin inhibits the proliferation of VEGFR2-expressing cells in vitro and is considered to be a significant achievement in tumor therapy and it forms a basis for further studies in animal models.
Journal ArticleDOI

Generation of a functional monomolecular protein lattice consisting of an s-layer fusion protein comprising the variable domain of a camel heavy chain antibody.

Magdalena Pleschberger, +7 more
- 12 Feb 2003 - 
TL;DR: The functionality of the fused cAb-Lys3 in the S-layer fusion protein was proved by surface plasmon resonance measurements and Dot blot assays revealed that the accessibility of the fusion functional sequence for the antigen was indepe...
Journal ArticleDOI

Parallel selection of multiple anti-infectome Nanobodies without access to purified antigens.

Dirk Saerens, +8 more
- 01 Jan 2008 - 
TL;DR: Nanobodies, camelid-derived single-domain antibody fragments, are a valuable source for validation of novel, not yet identified targets to design new diagnostics and therapeutics.
Journal ArticleDOI

Nanoimmunoassay onto a screen printed electrode for HER2 breast cancer biomarker determination

Stéphanie Patris, +6 more
- 01 Dec 2014 - 
TL;DR: Determination of HER2 in human cells has been realized and the amperometric signal obtained was proportional to the logarithm of Her2 concentration between 1 and 200 µg/mL and the modified SPE storage stability lasted for at least three weeks.